{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:44:11Z","timestamp":1786985051624,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R21AG049137"],"award-info":[{"award-number":["R21AG049137"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.bbrc.2021.08.049","type":"journal-article","created":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T11:13:21Z","timestamp":1629458001000},"page":"85-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Inhibition of alpha-synuclein aggregation by AM17, a synthetic resveratrol derivative"],"prefix":"10.1016","volume":"574","author":[{"given":"Edward","family":"Chau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunjoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0951-0587","authenticated-orcid":false,"given":"Jineun","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6156-8730","authenticated-orcid":false,"given":"Jin Ryoun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2021.08.049_bib1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.tins.2018.09.007","article-title":"Triggers, facilitators, and aggravators: redefining Parkinson's disease pathogenesis","volume":"42","author":"Johnson","year":"2019","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbrc.2021.08.049_bib2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.bbadis.2011.10.002","article-title":"Alpha-synuclein misfolding and Parkinson's disease","volume":"1822","author":"Breydo","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2021.08.049_bib3","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nrn3549","article-title":"Parkinson's disease dementia: convergence of alpha-synuclein, tau and amyloid-beta pathologies","volume":"14","author":"Irwin","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbrc.2021.08.049_bib4","doi-asserted-by":"crossref","first-page":"9141","DOI":"10.1073\/pnas.92.20.9141","article-title":"NACP, the precursor protein of the non-amyloid beta\/A4 protein (A beta) component of Alzheimer disease amyloid, binds A beta and stimulates A beta aggregation","volume":"92","author":"Yoshimoto","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2021.08.049_bib5","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1074\/jbc.M008919200","article-title":"A\u00a0hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein is essential for filament assembly","volume":"276","author":"Giasson","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2021.08.049_bib6","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1002\/cbic.201100430","article-title":"Creation of aggregation-defective alpha-synuclein variants by engineering the sequence connecting beta-strand-forming domains","volume":"12","author":"Hernandez","year":"2011","journal-title":"Chembiochem"},{"key":"10.1016\/j.bbrc.2021.08.049_bib7","doi-asserted-by":"crossref","first-page":"13709","DOI":"10.1021\/bi961799n","article-title":"NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded","volume":"35","author":"Weinreb","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbrc.2021.08.049_bib8","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1006\/jmbi.2001.4538","article-title":"Conformational properties of alpha-synuclein in its free and lipid-associated states","volume":"307","author":"Eliezer","year":"2001","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.bbrc.2021.08.049_bib9","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jmb.2005.10.071","article-title":"Secondary structure of alpha-synuclein oligomers: characterization by Raman and atomic force microscopy","volume":"355","author":"Apetri","year":"2006","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.bbrc.2021.08.049_bib10","doi-asserted-by":"crossref","first-page":"6806","DOI":"10.1021\/acs.analchem.0c00593","article-title":"Structural characterization of individual alpha-synuclein oligomers formed at different stages of protein aggregation by atomic force microscopy-infrared spectroscopy","volume":"92","author":"Zhou","year":"2020","journal-title":"Anal. Chem."},{"key":"10.1016\/j.bbrc.2021.08.049_bib11","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1042\/BJ20111924","article-title":"Toxic prefibrillar alpha-synuclein amyloid oligomers adopt a distinctive antiparallel beta-sheet structure","volume":"443","author":"Celej","year":"2012","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbrc.2021.08.049_bib12","doi-asserted-by":"crossref","first-page":"8637","DOI":"10.1073\/pnas.0712179105","article-title":"The fold of alpha-synuclein fibrils","volume":"105","author":"Vilar","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2021.08.049_bib13","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1126\/science.1079469","article-title":"Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis","volume":"300","author":"Kayed","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2021.08.049_bib14","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1073\/pnas.1100976108","article-title":"In\u00a0vivo demonstration that alpha-synuclein oligomers are toxic","volume":"108","author":"Winner","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2021.08.049_bib15","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/jnc.14808","article-title":"alpha-synuclein oligomers and fibrils: a spectrum of species, a spectrum of toxicities","volume":"150","author":"Alam","year":"2019","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.bbrc.2021.08.049_bib16","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1038\/s41467-021-21937-3","article-title":"The release of toxic oligomers from alpha-synuclein fibrils induces dysfunction in neuronal cells","volume":"12","author":"Cascella","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2021.08.049_bib17","doi-asserted-by":"crossref","first-page":"14465","DOI":"10.1523\/JNEUROSCI.2246-12.2012","article-title":"NADPH oxidase 1 mediates alpha-synucleinopathy in Parkinson's disease","volume":"32","author":"Cristovao","year":"2012","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.bbrc.2021.08.049_bib18","doi-asserted-by":"crossref","first-page":"104484","DOI":"10.1016\/j.neuint.2019.104484","article-title":"A\u00a0secret that underlies Parkinson's disease: the damaging cycle","volume":"129","author":"Sun","year":"2019","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bbrc.2021.08.049_bib19","doi-asserted-by":"crossref","first-page":"8134","DOI":"10.1021\/bi1010909","article-title":"Redox reactions of the alpha-synuclein-Cu(2+) complex and their effects on neuronal cell viability","volume":"49","author":"Wang","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbrc.2021.08.049_bib20","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1471-4159.2010.06638.x","article-title":"Copper binding regulates intracellular alpha-synuclein localisation, aggregation and toxicity","volume":"113","author":"Wang","year":"2010","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.bbrc.2021.08.049_bib21","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.bbrc.2009.01.103","article-title":"Metal binding to alpha-synuclein peptides and its contribution to toxicity","volume":"380","author":"Brown","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2021.08.049_bib22","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fnins.2017.00114","article-title":"Metallothionein, copper and alpha-synuclein in alpha-synucleinopathies","volume":"11","author":"Okita","year":"2017","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bbrc.2021.08.049_bib23","doi-asserted-by":"crossref","first-page":"105046","DOI":"10.1016\/j.neuint.2021.105046","article-title":"Development of grape polyphenols as multi-targeting strategies for Alzheimer's disease","volume":"147","author":"El Gaamouch","year":"2021","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bbrc.2021.08.049_bib24","doi-asserted-by":"crossref","first-page":"24228","DOI":"10.1074\/jbc.M110.133108","article-title":"Resveratrol selectively remodels soluble oligomers and fibrils of amyloid Abeta into off-pathway conformers","volume":"285","author":"Ladiwala","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2021.08.049_bib25","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.bbrc.2003.08.105","article-title":"Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses","volume":"309","author":"Leonard","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2021.08.049_bib26","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13578-020-00491-3","article-title":"Molecular and biological functions of resveratrol in psychiatric disorders: a review of recent evidence","volume":"10","author":"Shayganfard","year":"2020","journal-title":"Cell Biosci."},{"key":"10.1016\/j.bbrc.2021.08.049_bib27","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1016\/j.bmc.2016.06.012","article-title":"Ionophoric polyphenols selectively bind Cu(2+), display potent antioxidant and anti-amyloidogenic properties, and are non-toxic toward Tetrahymena thermophila","volume":"24","author":"Martinez","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bbrc.2021.08.049_bib28","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1007\/s00044-020-02615-3","article-title":"Ionophoric polyphenols are permeable to the blood-brain barrier, interact with human serum albumin and Calf Thymus DNA, and inhibit AChE enzymatic activity","volume":"29","author":"Martinez","year":"2020","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bbrc.2021.08.049_bib29","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3389\/fnagi.2020.00103","article-title":"Resveratrol derivatives as potential treatments for alzheimer's and Parkinson's disease","volume":"12","author":"Arbo","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.bbrc.2021.08.049_bib30","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1007\/s11064-020-03058-3","article-title":"Promising polyphenols in Parkinson's disease therapeutics","volume":"45","author":"Singh","year":"2020","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbrc.2021.08.049_bib31","doi-asserted-by":"crossref","first-page":"10712","DOI":"10.1039\/c3cc44804e","article-title":"A\u00a0conformation-switching fluorescent protein probe for detection of alpha synuclein oligomers","volume":"49","author":"Hernandez","year":"2013","journal-title":"Chem. Commun."},{"key":"10.1016\/j.bbrc.2021.08.049_bib32","first-page":"91","article-title":"Ultraviolet absorption spectroscopy","volume":"40","author":"Mach","year":"1995","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bbrc.2021.08.049_bib33","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1021\/acs.biochem.9b00655","article-title":"Interactions between soluble species of beta-amyloid and alpha-synuclein promote oligomerization while inhibiting fibrillization","volume":"59","author":"Candreva","year":"2020","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbrc.2021.08.049_bib34","doi-asserted-by":"crossref","first-page":"9303","DOI":"10.1021\/ic901157w","article-title":"Identification of the minimal copper(II)-binding alpha-synuclein sequence","volume":"48","author":"Jackson","year":"2009","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.bbrc.2021.08.049_bib35","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1073\/pnas.0407881102","article-title":"Structural characterization of copper(II) binding to alpha-synuclein: insights into the bioinorganic chemistry of Parkinson's disease","volume":"102","author":"Rasia","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2021.08.049_bib36","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1021\/acschemneuro.7b00149","article-title":"Perturbation in long-range contacts modulates the kinetics of amyloid formation in alpha-synuclein familial mutants","volume":"8","author":"Ranjan","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bbrc.2021.08.049_bib37","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.bbapap.2017.02.014","article-title":"Polyphenols in combination with beta-cyclodextrin can inhibit and disaggregate alpha-synuclein amyloids under cell mimicking conditions: a promising therapeutic alternative","volume":"1865","author":"Gautam","year":"2017","journal-title":"Biochim. Biophys. Acta Protein Proteonomics"},{"key":"10.1016\/j.bbrc.2021.08.049_bib38","doi-asserted-by":"crossref","first-page":"44284","DOI":"10.1074\/jbc.M105343200","article-title":"Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure","volume":"276","author":"Uversky","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2021.08.049_bib39","doi-asserted-by":"crossref","first-page":"10737","DOI":"10.1074\/jbc.M010907200","article-title":"Evidence for a partially folded intermediate in alpha-synuclein fibril formation","volume":"276","author":"Uversky","year":"2001","journal-title":"J.\u00a0Biol. Chem."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X21012262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X21012262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T14:41:33Z","timestamp":1762094493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X21012262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":39,"alternative-id":["S0006291X21012262"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2021.08.049","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of alpha-synuclein aggregation by AM17, a synthetic resveratrol derivative","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2021.08.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}